NCT02912559 2026-02-02
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
6 trialsNCT05870800 2025-05-25
NICER
Baylor College of Medicine
Phase 2 Recruiting
NCT05482516 2025-05-22
MRD-GI
Georgetown University
Phase 3 Recruiting
NCT04108481 2025-03-28
iRE-C
University of Iowa
Phase 1 Terminated
NCT05456165 2024-12-31
Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer
Gritstone bio, Inc.
Phase 2 Withdrawn
NCT03698461 2024-01-31
CLIMB
Asan Medical Center
Phase 2 Completed